ASKA Pharmaceutical Holdings Co (TSE:4886) Total Liabilities: 円35,561 Mil (As of Mar. 2026)


TSE:4886 ASKA Pharmaceutical Holdings Co Ltd TSE:4886
61 GF Score
Price 円2,259.00
GF Value 円2,400.87
Valuation Fairly Valued
View Full Analysis

What is ASKA Pharmaceutical Holdings Co Total Liabilities?

ASKA Pharmaceutical Holdings Co TSE:4886 -1.27% 61 Total Liabilities is 円35,561 Mil as of Mar. 2026. GuruFocus rates TSE:4886 with a GF Score™ of 61/100 and a GF Value™ of 円2,400.87 (Fairly Valued).

ASKA Pharmaceutical Holdings Co's Total Liabilities for the quarter that ended in Mar. 2026 was 円35,561 Mil.

ASKA Pharmaceutical Holdings Co's quarterly Total Liabilities increased from Sep. 2025 (円36,181.00 Mil) to Dec. 2025 (円37,958.00 Mil) but then declined from Dec. 2025 (円37,958.00 Mil) to Mar. 2026 (円35,561.00 Mil).

ASKA Pharmaceutical Holdings Co's annual Total Liabilities increased from Mar. 2024 (円28,816.00 Mil) to Mar. 2025 (円32,482.00 Mil) and increased from Mar. 2025 (円32,482.00 Mil) to Mar. 2026 (円35,561.00 Mil).

ASKA Pharmaceutical Holdings Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for ASKA Pharmaceutical Holdings Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASKA Pharmaceutical Holdings Co Total Liabilities Chart

ASKA Pharmaceutical Holdings Co Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
34,406.00 32,607.00 28,816.00 32,482.00 35,561.00

ASKA Pharmaceutical Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32,482.00 33,721.00 36,181.00 37,958.00 35,561.00
TSE:4886
61GF Score
ASKA Pharmaceutical Holdings Co Ltd TSE:4886
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ASKA Pharmaceutical Holdings Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

ASKA Pharmaceutical Holdings Co's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=22291+(8165+5082
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+23+0)
=35,561

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=112379-76818
=35,561

ASKA Pharmaceutical Holdings Co's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=22291+(8165+5082
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+23+0)
=35,561

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=112379-76818
=35,561

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of 円35,561 Mil mean?
ASKA Pharmaceutical Holdings Co (TSE:4886) has a Total Liabilities of 円35,561 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ASKA Pharmaceutical Holdings Co and its competitors.
Is ASKA Pharmaceutical Holdings Co's Total Liabilities too high?
ASKA Pharmaceutical Holdings Co's current Total Liabilities is 円35,561 Mil. Overall, ASKA Pharmaceutical Holdings Co has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does ASKA Pharmaceutical Holdings Co's Total Liabilities compare to ZTS and UTHR?
ASKA Pharmaceutical Holdings Co's Total Liabilities of 円35,561 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ASKA Pharmaceutical Holdings Co and its competitors. ASKA Pharmaceutical Holdings Co's current Total Liabilities is 円35,561 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASKA Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co (TSE:4886) is currently considered Fairly Valued. The stock's GF Value™ is 円2,400.87, compared to a current price of 円2,259.00 — trading 5.9% below its estimated fair value. The current Total Liabilities is 円35,561 Mil. ASKA Pharmaceutical Holdings Co's overall GF Score™ is 61/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For ASKA Pharmaceutical Holdings Co (TSE:4886), the current Total Liabilities is 円35,561 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ASKA Pharmaceutical Holdings Co (TSE:4886) Overvalued in 2026?

Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co stock appears to be undervalued. The current stock price of 円2,259.00 is trading 5.9% below its estimated GF Value™ of 円2,400.87. GuruFocus considers ASKA Pharmaceutical Holdings Co to be Fairly Valued.

Key valuation signals for TSE:4886:

  • Total Liabilities: 円35,561 Mil
  • GF Value™: 円2,400.87 vs. price of 円2,259.00 (5.9% below fair value)
  • GF Score™: 61/100

No single metric tells the full story. See the TSE:4886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ASKA Pharmaceutical Holdings Co Business Description

Address 2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and other related operations.
61GF Score

Get the complete analysis for TSE:4886

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,259.00
Price
円2,400.87
GF Value